1. Home
  2. SLMT vs NEPH Comparison

SLMT vs NEPH Comparison

Compare SLMT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brera Holdings PLC Class B Ordinary Shares

SLMT

Brera Holdings PLC Class B Ordinary Shares

HOLD

Current Price

$4.22

Market Cap

42.6M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.26

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLMT
NEPH
Founded
2000
1997
Country
Ireland
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
40.1M
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
SLMT
NEPH
Price
$4.22
$4.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
41.4K
30.6K
Earning Date
06-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.12
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$35.17
Revenue Growth
N/A
32.67
52 Week Low
$0.56
$2.66
52 Week High
$24.05
$6.42

Technical Indicators

Market Signals
Indicator
SLMT
NEPH
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SLMT
NEPH

About SLMT Brera Holdings PLC Class B Ordinary Shares

Solmate Infrastructure Public Ltd is a Solana-based crypto infrastructure company with a strategic focus on Abu Dhabi. The group builds high-performance validators that lower latency, expand network reach, and position Abu Dhabi as a world-wide hub for Solana infrastructure. The company creates value by working with its partners to build infrastructure and real hardware for the crypto revolution. Its cutting-edge Solana staking infrastructure will help drive the adoption of the network in the Middle East.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: